[1]
Shaw, K. et al. 2018. PHARMACOGENOMIC INVESTIGATION OF ADVERSE DRUG REACTIONS (ADRS): THE ADR PRIORITIZATION TOOL, APT. Journal of Population Therapeutics and Clinical Pharmacology. 20, 2 (Nov. 2018).